Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mary T. Szela currently holds 752,987 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary T. Szela has been a net seller of ABT stock. They have purchased $100.2K and sold $8.1M worth of shares.
Mary T. Szela's most recent insider trade was on Mar 17, 2026, when they sold 15,944 shares at $3.85 per share.
Mary T. Szela serves as Executive at ABBOTT LABORATORIES (ABT). They have executed 125 insider transactions totaling $8.2M over their tenure at the company.
Mary T. Szela holds the position of Executive at ABBOTT LABORATORIES, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mary T. Szela has shown a selling trading pattern, with $100.2K in total purchases and $8.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mary T. Szela was on Dec 14, 2011, when they sold $2.9M worth of ABT shares. This transaction involved 53,201 shares at $53.63 per share.
Mary T. Szela currently owns 752,987 shares of ABBOTT LABORATORIES (ABT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mary T. Szela's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mary T. Szela has 125 Form 4 filings on record as an insider at ABBOTT LABORATORIES.
Set alerts for Mary T. Szela and 40,000+ other insiders.